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From the New England Society for Vascular Surgery
The care of the patient with vascular disease
Magruder C. Donaldson, MD, Framingham, MassThe annual Presidential Address is an occasion for
reflection and perspective, like our annual society meetings
a chance to tip back and look at the big picture together.
Such discussion often focuses on our horizons and new
frontiers, most appropriate given the changes in knowl-
edge, technology, training, and practice affecting our lives
so dramatically in recent years. Although there has been
periodic examination of our identity as vascular surgeons,
the emphasis has usually been on distinctions between us
and cardiologists or interventional radiologists, frequently
focusing most intensively on technologic precedent and
prowess.
Armed with the license afforded on the occasion of this
address, I would like to look above the trees of the forest for
an overview of our ultimate purpose of taking care of
people with vascular disease. By highlighting some of the
less tangible, more challenging, and therefore sometimes
neglected needs of our patients, I hope to further redefine
the character of those who rise tomeet those needs. I would
especially hope that these observations are taken to heart as
we introduce new paradigms for educating the vascular
specialists of the future and as we lead improvements in our
systems of patient care.
THE PATIENT WITH VASCULAR DISEASE
To orient the discussion, I want to enumerate some of
the salient characteristics and challenges presented by pa-
tients with vascular diseases in 2006.
First, a wide variety of vascular diseases affect people
from all walks of life in an array of often profound and
extraordinary ways. On a typical day, we are pitched a wild
mixture of fastballs, curve balls, and change-ups. Consider:
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doi:10.1016/j.jvs.2006.10.019● 20-year-old skier with frostnip of the finger and his
friend with a painful pulsatile mass protruding above
his recently fractured clavicle;
● the youngmother with varicose veins and her pregnant
sister with ileofemoral thrombosis;
● the middle-aged mailman with claudication and his
bus driver neighbor with sudden onset of foot pain 6
months after a composite vein graft;
● the recent retiree with transient ischemic attacks and
his golfing partner recovering from a small stroke
suffered 3 days ago;
● the healthy elderly man concerned about his asymp-
tomatic 5.6-cm abdominal aortic aneurysm (AAA) and
his frail, scoliotic sister with a 5.6-cm AAA and back
pain;
● the nonambulatory nonagenarian suffering from a
painful heel ulcer after a stroke and his nursing home
roommate whose heel ulcer is complicated by deep
sepsis and collapse.
Provision of comprehensive care for such a fascinating
mix defies a simple, industrial production line approach and
challenges us to grasp each patient’s unique problem by
understanding not only the relevant facts of his medical
history but also, most importantly, the key elements of his
life as well.
Second, within the context of this variety, an increasing
number of our patients are in the oldest age groups. Aver-
age life expectancy is 80 years for a baby born today and
10 years for today’s 80-year-olds, according to the Inter-
nal Revenue Service. The 2000 United States census doc-
umented 34.9 million Americans older than age 65, 12.4%
of the overall population, increased by 3.7 million since
1990. In 2000, 4.2 million Americans were older than age
85 and 340,000 were older than 95.1
Quite aside from their medical problems, older patients
are accompanied by the generic issues related to aging itself.
I recall a very healthy, rational 86-year-old woman in whom
an asymptomatic 7.0-cm AAA had been discovered. I as-
sumed she was coming to seeme to eliminate the aneurysm,
but when I embarked on a discussion of the options for
repair she interrupted me to explain that she was not
interested in treatment. Upon further conversation she
made it clear that her only concern as she grew older was
finding herself chronically ill, incapacitated and helplessly
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a relief to her, since it might provide her with a simple “exit
strategy,” as she termed it. Our conversation shifted to
counseling on what to expect if the AAA ruptured, and she
left quite content with plans for palliative care to share with
her primary care physician. We are challenged to under-
stand our patients’ concerns about discomfort, incapacity,
dependency and control of end-of-life events.
Third, many vascular diseases arise from lifestyle and
behavioral causes that are, in theory, preventable or con-
trollable. The fact that many of our patients suffer from
illness that is to some extent self-inflicted is a familiar and
frustrating characteristic. Framingham Heart Study data
have shown that the risk of coronary heart disease and
stroke is directly correlated with prevalence of well-known
risk factors.2,3 Among those, smoking and obesity are the
most importantmodern culprits rooted in human behavior.
Patients’ noncompliance with our advice continues to sig-
nificantly impact the efficacy and durability of many of our
high-tech interventions. Our patients present us with a
special challenge to engage the behavioral, social, and
economic reasons for their noncompliant and unhealthy
practices.
Fourth, vascular disease is now often detected at an
early preclinical stage of its natural history. Screening strat-
egies that use safe and accurate imaging of vascular struc-
tures as well as sensitive blood assays have been validated
and are in common use.4 The work of The American
Vascular Association (AVA) has facilitated ultrasound
screening for peripheral vascular disease, carotid disease,
and AAA in our own vascular laboratories. An assay for
C-reactive protein is now routinely added to testing for
homocysteine and lipids. To address our patients’ surprised
concern after revelation of an unexpected condition, we are
challenged to provide them with full counsel on our under-
standing of the pathogenesis and natural history of the
disease and the trade-offs related to each management
option.
Fifth, our patients have access to more information
about vascular disease and its treatment than ever before.
The public is deluged by media coverage of exciting med-
ical news, by educational efforts of government and profes-
sional organizations such as The Society for Vascular Sur-
gery (SVS) and the AVA, and by direct marketing of
services, products and devices by industry, hospitals, and
doctors. The Internet has had a phenomenal impact, even
among our older patients. Today our patients have infor-
mation about the quality and price of care available at each
of our hospitals and in each of our hands. An inevitable
byproduct of this profusion of information is misunder-
standing and confusion. In a complex era of direct market-
ing, potential conflicts of interest, and secondary gains, we
are challenged to keep ourselves up to date with the truth
behind the headlines and to remain engaged in open and
objective discussion with our patients.
Sixth, the high prevalence of comorbidity and associ-
ated illnesses compounds the complexity of the needs of
our patients with vascular disease.5,6 Although heart diseaseand stroke are less commonly causing death these days, the
American Heart Association reported a substantial preva-
lence of coronary disease, stroke, hypertension, hypercho-
lesterolemia, sedentary lifestyle, diabetes, and obesity in
2003 and 2004 (Table I).7 Furthermore, the prevalence of
diabetes is rising alarmingly, along with its attendant mul-
tisystem disorders. Our clinics are full of patients with
problems that are both accelerated and complicated by one
or more form or comorbidity.5 Consider the 300-pound
smoker with hypertension and coronary disease struggling
with diabetes, renal dysfunction, arteriopathy and an
undrained foot infection. To guide our patients safely to
recovery, we are challenged not only to understand their
diseases and to orchestrate the necessary diagnostic and
therapeutic resources but also to effectively engage them in
the effort, eye-to-eye.
Finally, the complexity of patients with vascular
disorders can create confusion among health care providers
during the process of triage, diagnosis and treatment. Pri-
mary care physicians are finding it more and more difficult
to direct patient traffic, and economic and logistic pressures
emphasizing quantity rather than quality of care adversely
affect both primary care and specialty physicians.8,9 As a
result, patients may land in limbo between referrals, and
vascular consultants may find themselves pinch hitting for
primary care physicians or other specialists.
During triage and diagnosis, vascular doctors play a role
in untangling nonspecific complaints such as leg pain and
dizziness which frequently turn out to be nonvascular in
origin. Although many of us find this characteristic appeal-
ing, few would have taken it as far as I did when the
realization that none of my referring doctors knew much
about “legology” resulted in a handbook on leg pain.10
Multidisciplinary sharing of wisdom and coordination of
efforts is intrinsic to the process of developing a good plan
to fit each patient’s complicated situation. We are chal-
lenged to work respectfully with our colleagues to orches-
trate smooth, safe, and stress-free evaluation and treatment
Table I. Prevalence of cardiovascular diseases and risk
factors, 2003*
Disease/
risk factor
Males,
n† (%)
Females,
n† (%)
Total,
n† (%)
Total CVD 33.1 (34.4) 38.2 (33.9) 71.3 (34.2)
CHD 7.2 (8.4) 6.0 (5.6) 13.2 (6.9)
Stroke 2.3 (2.5) 3.1 (2.6) 5.5 (2.6)
Hypertension 29.4 (30.5) 35.6 (31.8) 65.0 (32.3)
Tobacco use 24.1 (23.4) 20.2 (18.5) 44.3 (20.9)
Cholesterol 240 16.4 (16.3) 18.1 (17.8) 34.5 (17.3)
Physical activity 31.4% 29.0% 30.1%
Obesity BMI 30.0 27.9 (27.6) 36.1 (33.2) 64.0 (30.4)
Diabetes 7.0 (7.2) 7.1 (6.3) 14.1 (6.7)
CVD,Cardiovascular disease;CHD, coronary heart disease; BMI, bodymass
index.
*American Heart Association-Heart Disease and Stroke Statistics-2006
Update. http://www.americanheart.org/statistics.
†Numbers in millions.of our patients.
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On reflection (Table II), it is clear that the challenges
brought to us by patients with vascular disease create de-
mands for care that extend well beyond the limitations of
the logical algorithmic pathways, slick procedures and crisp
technical maneuvers with which we are tempted to define
and pride ourselves. These challenges can only be ade-
quately met by acknowledging the human dimensions of
care and paying attention to people, both our patients and
our fellow caregivers. I hope this point will be made more
obvious as we highlight several elements of today’s care that
deserve special emphasis in this regard.
First, how can we care for the patient without caring
about prevention? In fact, public health initiatives have
made great strides in this direction. For example, the cam-
paign against smoking deserves credit for the fact that
Americans smoked fewer cigarettes in 2005 than in any year
since 1951, with per capita consumption at levels not seen
since the 1930s. Cigarette sales tax figures indicated a drop
in sales of 20% since 1998.11 Data from the Centers for
Disease Control and Prevention lend credence12 to the
efforts of physicians using a widening array of medications
to manipulate many known risk factors.13 Although the
value of exercise and weight loss has been repeatedly dem-
onstrated, the impact of these measures has been less no-
ticeable, in large part because of inadequate availability and
use of tools to deal with intractable patient behavior.14,15
Efforts to improve behavior are no less applicable to
givers of care than to receivers of care. Even with compel-
ling data and vigorous campaigns to “Get With the Guide-
lines” (Table III),16,17 there is evidence that we all need to
work much harder on uniform application of preventive
measures.18 Vascular surgeons have been deferential with
respect to managing medications and exercise, weight loss
and smoking cessation efforts for their patients. With all
due respect for our colleagues in medicine, I would submit
that their wide overview and experience as “vasculologists”
fully qualifies vascular surgeons to assume more responsi-
bility for the initiation and management of these critical
preventive measures. In addition to outpatient primary and
secondary preventive measures, our frequent presence dur-
ing the more dramatic stages of disease gives us unusual
leverage to change unhealthy patient habits.
Noninterventional preventive strategies certainly per-
tain to the enlarging subset of patients in whom preclinical
or minimally symptomatic disease is picked up by incidental
finding or screening. These patients have stimulated us to
Table II. Salient features of patients with vascular disease
Variety
Older age
Preventable Causes
Preclinical Detection
Lots of Information
Lots of Comorbidity
Lots of Doctorsclarify our understanding of natural history, the impact ofvarious forms of conservative therapy, and the risks, costs
and benefits of a widening array of anatomic interventions.
Although our understanding is certainly not complete, the
availability of less morbid therapies has created a firm tilt in
our stance towards preemptive intervention for smaller
AAAs, asymptomatic carotid and renal artery stenoses, and
mild-to-moderate disease of the iliac and superficial femoral
arteries. In days past, intervention for any of these lesions
was not pursued unless a satisfactory answer could be
provided to the question “Why intervene?” In 2006, the
question is more typically a cautious “Why not intervene?”
Our answers to our patients must calibrate the objective
evidence about natural history, risk and efficacy, as well as
the subjective impact of marketing, preference, cost, and
competition on both our patients and ourselves.
This leads us to a second concern. How can we care for
the patient without caring about quality and value? Our
long surgical tradition of examining results, founded on the
work of Boston surgeon E.A. Codman, is amply manifest
through leadership in ongoing activities such as develop-
ment of reporting standards, participation in the National
Surgical Quality Improvement Program (NSQIP) and
seminal support of national registries for endovascular an-
eurysm repair and carotid artery stenting. As individuals, a
distinctive character trait exemplified by Robert Linton’s
legacy of “doing it right” has been imprinted onmany of us
in New England and beyond, setting high standards of
devotion to excellence and the integrity and tenacity nec-
essary to achieve it.19
We have all experienced the thrill of victory that re-
wards skilled persistence at the end of a revascularization
procedure. A similar although less palpable thrill is intrinsic
to knowing you have done the best for your patient,
without being tempted by an expedient “Plan B” short cut
rather than “Plan A.” We must continue to emphasize this
tradition as we work with our colleagues in industry and
related vascular fields, particularly as we evaluate new ther-
Table III. American Heart Association/American
College of Cardiology Guidelines for
Secondary Prevention16
Intervention point Guideline goal
Smoking Complete cessation
Blood pressure control 140/90; 130/80 in diabetics
Lipid management/
statin use LDL cholesterol 100 mg/dL
Physical activity 30 min, 3 times/week
Weight management BMI 25
Diabetes management HbA1c 7%
Antiplatelet/
anticoagulant use Use in all if not contraindicated
ACE inhibitor use Use in all post MI, consider in others
-blocker use Use in all post MI, in others as
indicated for hypertension,
arrhythmia, and angina
LDL, Low-density lipoprotein; BMI, body-mass index; Hb, hemoglobin;
ACE, angiotensin-converting enzyme; MI, myocardial infarction.apeutic modalities and adapt to new practice patterns.
JOURNAL OF VASCULAR SURGERY
February 2007430 DonaldsonPatient satisfaction surveys are now widely used by
hospitals and others to measure quality. The idea of directly
asking the recipients of our care how we are doing makes
sense, although using tools developed for car dealerships,
such as a mail-in survey of our “customers,” may not be the
most appropriate way to ask.
I would submit that the key components of patient
satisfaction typically do not include the doctor’s curriculum
vitae or his technical prowess, but reside within the human
dimension. Spending adequate time with a patient to un-
derstand him, explain his problem and its solutions, and
respond to questions and concerns displays our respect and
commitment. We must resist the relentless pressures to
shortchange this ingredient of our care. There is no ques-
tion in my mind that strengthening the human content of
our relationships to patients can only reduce stress and
inefficiency during the process of care and improve the
results of care, no matter how they are measured.
Frugality is a trait frequently caricatured among New
Englanders, thereby qualifying them to take the lead on
evaluation of value and control of waste. According to a
recent report, average health care spending per year of life
gained has increased significantly during the last 40 years,
most dramatically among patients aged 65 in whom we
currently spend about $150,000 per year gained.20 Most of
this expenditure is undoubtedly worthwhile, but given its
magnitude we must remain ever vigilant both locally and
globally.
Of course, the real issue is not cost per se but value in
exchange for expenditures of time, energy, and money.
Vigorous ongoing efforts to identify the elements of our
care that are of most value assist our everyday choices of
whether to stent a long superficial femoral artery occlusion,
do a PTFE bypass, or perform a vein bypass, for example.
Application of the powerful tools of decision analysis to
these complex decisions remains very useful.21-23 I would
point out, however, that most of the tools we currently use
are incapable of factoring in the less tangible but critical
value of the human ingredients of care that deserve more
emphasis. Although we support the efforts of government,
third-party insurers, and hospitals to make objective quality
and cost data available to encourage rational choice, we
must recognize the validity of the subjective and less ratio-
nal factors that contribute to our decisions and to successful
care.
Third, how can we care for the patient without
assuring access to comprehensive therapy? The number
and variety of treatment options currently available to
treat patients with vascular disease is unprecedented.
Assuming up-to-date information about the patient and
each therapeutic option, each of us has the wherewithal
to objectively analyze the real problem and lay out its
theoretic solutions. To take the next step and arrive at
sound advice for optimal care of patients from all walks of
life,24 we must consider practical issues such as availabil-
ity of experienced and skilled staff, physical resources,
and subspecialty support.For example, vascular subspecialists are generally well
trained, equipped, and skilled at endovascular methods.
Even most of the old dogs among us have successfully met
the challenge of learning new tricks, thus enhancing their
capabilities. Colleagues in industry and related specialties
have provided generous support in this endeavor. Some of
us have been tempted by enthusiasm to “do it all,” even at
risk of ignoring Linton’s call to “do it right.” Such hubris is
ill advised and particularly dangerous if one’s armamentar-
ium is based on a single technical modality or venue,
recalling the cautionary adage: “If you have a hammer the
whole world looks like a nail.” We have learned first hand
that hammers evolve rapidly.Wemust maintain a firm focus
on our patients and their diseases, not on technology and
passing fads.
The fact of the matter is that we cannot provide best
vascular care without teamwork. We are fortunate that
there are others who have expertise in vascular care, and
they should be valued as an asset, not spurned as a threat. A
survey of resources at each of our institutions will identify
strengths in many medical and surgical specialties and allied
support services. In most instances, individuals from vari-
ous disciplines have worked together informally for years.
To realize the full multiplier effects expressed by the con-
cept “one plus one equals three,” each institution must
formalize and coordinate these elements into its own
unique vascular care team.
Beyond our individual and institutional qualifications,
we must honestly assess the capabilities of our home teams
to “do it all” and “do it right.” Because staffing for inten-
sive care and recovery from large surgical procedures is not
often necessary for AAA endografting or percutaneous
femoral intervention, the endovascular era has made care
available to more patients at smaller hospitals outside of the
tertiary sphere. In fact, this venue may be well suited to
modern interventional care, given generally lower costs and
easier access for patients and their families, among other
reasons. Despite ongoing trends in this direction, there will
always be patients whose immediate needs exceed local
resources or who require adjunctive or unexpected care of a
more complicated nature. We must enhance rational re-
gional cooperative and supportive teamwork to facilitate
choice of the most appropriate venue for each patient’s
care.
The prolific 19th century French satirist, Honore
Daumier, created a drawing in his “Les Gens deMedecine”
series in which a patient is surrounded by three specialists
offering their patient the best care available (Fig 1). On
examination, it appears that Daumier may have captured
modern day representatives of the specialties of medicine,
surgery, and interventional radiology. In 2006, the ability
of caregivers to work together is blurring the distinctions
between these specialists and enabling additional talented
participants to join the circle.
Finally, how can we care for the patient without caring
for the patient? Somemay recall the 1976 speech before the
Massachusetts Medical Society by J. Englebert Dunphy
titled, “On Caring for the Patient with Cancer.”25 It is also
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Patient,” part of a series given to Harvard medical students
in the late 1920s and 1930s by Francis W. Peabody.26
Peabody wrote:
The good physician knows his patients through and
through, and his knowledge is bought dearly. Time,
sympathy, and understanding must be lavishly dispensed,
but the reward is to be found in that personal bond which
forms the greatest satisfaction of the practice of medicine.
One of the essential qualities of the clinician is interest in
humanity, for the secret of the care of the patient is in
caring for the patient.
As excerpted, Peabody reminds us that the enduring
reality connecting us to our patients and validating our role
as physicians is our common human ground. Reflecting on
the nature of our patients and their vascular diseases, it is
clear that their needs exceed care we can provide by a pill,
catheter, or scalpel. To go the extra mile for our patients,
we must stay focused on being doctors. More than one of
my role models expressed this commitment as “keeping
your eye on the ball.”
No doubt, there are many distractions, including the
intoxicating marketing glitz andmedia hyperbole driven by
business imperatives that create unrealistic expectations for
us to behave like superhuman video game heroes perform-
ing miracles without pain, scars, or complications. Similar
pressures have pushed us too far into the endless quest for
“productivity,” as tallied by numbers of office visits and
procedures. As a result, our day is in grave danger of
becoming dehumanized with loss of many of the key ingre-
dients of care.
Time, patience, and intangible connection are at the
heart of our patients’ needs and our ability to effectively
deliver the best care. In the language of current coding
terminology, we need to invest more time and effort on
patient evaluation and management (E & M) to under-
Fig 1. Daumier’s “Les Gens de Medecine.” Part of the public
domain.stand the patient’s personality, life situation, philosophy,and dreams. Only person-to-person communication and
contact can recruit the necessary motivation to comply with
preventive advice, the trust to allay anxiety, and the courage
to follow through with a scary therapeutic plan. We all have
experienced the salutary impact of such positive vibrations
on our patients as well as on ourselves and our colleagues as
healers. At the end of the day this intangible component is
what lingers strongest.
CONCLUSION
To be sure, this overview has been intentionally long
on vision and principle and short on practicalities. None-
theless, I firmly believe that these sentiments must re-
main our central inspiration and guide as we move
forward. With a tip of the hat to our colleagues in other
specialties, I would point out that by character, temper-
ament, training, and experience, modern surgeons are
unusually well equipped to meet the challenges of im-
proving comprehensive care for patients with vascular
disease. Furthermore, as reincarnated in recent years,
vascular surgeons have both an opportunity and an ob-
ligation to continue strengthening their leadership in
this endeavor. Once again, a Daumier figure may be
appropriate for the purpose of emphasizing this point
(Fig 2).
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